Shares of minimally invasive medical products provider InMode (NASDAQ:INMD) are soaring today on the company’s better-than-anticipated preliminary third-quarter numbers.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Revenue is seen lading between $120.5 million and $120.9 million, significantly ahead of the ~$106 million anticipated mark.
Further, bottom-line is seen landing between $0.64 and $0.65 per share.
Looking ahead, for the full year, InMode expects its top line to hover between $445 million and $450 million.
Read full Disclosure